Enovis (ENOV) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Enovis (ENOV) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | 11.06% |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | -6.18% |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 189.50% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | -54.61% |
| 10 | Enovis | 1.60 Bn | 1.56 Bn | 365.49 Mn | 113.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 113.99% |
| Dec 31, 2025 | 8.81% |
| Oct 3, 2025 | -710.51% |
| Jul 4, 2025 | 67.48% |
| Apr 4, 2025 | -190.70% |
| Dec 31, 2024 | -959.68% |
| Sep 27, 2024 | 19.27% |
| Jun 28, 2024 | 26.72% |
| Mar 29, 2024 | 60.36% |
| Dec 31, 2023 | -369.85% |
| Sep 29, 2023 | -25.58% |
| Jun 30, 2023 | -391.11% |
| Mar 31, 2023 | -1.89% |
| Dec 31, 2022 | 48.57% |
| Sep 30, 2022 | 27.60% |
| Jul 1, 2022 | 187.94% |
| Apr 1, 2022 | -281.47% |
| Dec 31, 2021 | 56.27% |
| Oct 1, 2021 | -261.32% |
| Jul 2, 2021 | 343.83% |